PPT-Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC

ORIGIN Pierre Amarenco Hans Denison Scott R Evans Anders Himmelmann Stefan James Mikael Knutsson Per Ladenvall Carlos A Molina Yongjun Wang S Claiborne . Jeanne Carroll, RN, BA, CCRC. 2. Ivorine Yu, PhD. 1. Fen-Lei Chang, MD, PhD. 1,2,3. 1. Indiana University School of Medicine – Fort Wayne. 2. Parkview Neuroscience and Stanley Wissman Stroke Center. Alexandra Czap MD. 1. , Jose-Miguel Yamal PhD. 2. , Noopur Singh MPH. 2. , Stephanie Parker RN. 1. , . Suja. . S. Rajan. PhD. 3. , . Ritvij. . Bowry. MD. 1. , James . Grotta. MD. 4. Department of Neurology, 2. Department of Biostatistics and Data Science, 3. Department of Management, Policy and Community Health . Giuseppe . Biondi-Zoccai. , MD. Sapienza University . of. . Rome. , Italy. giuseppe.biondizoccai@uniroma1.it. Learning. . goals. Scope . of. the . problem. Prasugrel. Ticagrelor. Reconciling. the . Approach to TIA and Management of Stroke after 4.5 hours Robert Altman R4 McGill University August 25 th 2010 Summer Emergency Lecture Series What to take out of today. Everything I’m presenting is Associate Professor of Clinical Pharmacy,. SBMU. CLASSIFICATION OF ANTIPLATELET AGENTS. Cyclooxygenase inhibitors. Aspirin. Platelet . P2Y12 receptor . blockers. clopidogrel, . ticlopidine. , . ticagrelor. SCENS. Learning Objectives. Complete a focused assessment on the patient presenting with signs and symptoms of a stroke. Initiate facility specific protocol for the patient presenting with an ischemic stroke. Preventing stroke. Primary prevention & lifestyle. Secondary prevention. Stroke unit care. TIA . pathways. Surgery. TPA. Johnston SC et al. Lancet 2007: 369; 283 - 92. Stroke risk after TIA can be high. S. Claiborne Johnston, MD, PhD. Dell Medical School. University of Texas, Austin. Potential Conflicts of Interest. P. rincipal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis.. Patients with TIA or Non Disabling Stroke Symptoms. New Acute TIA / Stroke Symptoms. Within 48 hrs and no ED Visit. Stroke Symptoms - MASH. likely TIA or minor stroke . (transient, fluctuating) & if persistent, increase triage . ,. Associate Professor, Pathology. Sri Venkateswara Institute of Medical Sciences. Trupathi. ISCHEMIC HEART DISEASE (IHD). IHD represents a group of . pathophysiologically. related syndromes resulting from myocardial ischemia – an . Current and Future. Published in journal of European neurology. On august 2022. INTRODUCTION. Despite progress in the . understanding of the pathophysiological mechanisms underlying stroke over the past 3 decades, concerning early diagnosis and the development of protocols that have reduced the door-to-needle time for acute ischemic stroke (AIS) treatment, several clinical gaps remain unsolved.. Luis Ortega-Paz, MD, PhD. 1. ; Francesco Franchi, MD. 1. ; Fabiana Rollini, MD1, Mattia Galli, MD. 1. ,. 2. Latonya Been, AAS. 1. , Ghussan Ghanem, MD. 1. , . Awss. . Shalhoub. , MD. 1. , Tiffany Ossi, MD. Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial. Gregg W Stone MD. Icahn School of Medicine at Mount Sinai. on behalf of Shao-Liang Chen and the ULTIMATE-DAPT Investigators. What effect does glycemic control with insulin have on these complications?. None. . Insulin does not improve mortality rates/neurological outcomes after stroke. Why do we care?. Stroke is the 5. th.